128 results
Page 2 of 7
S-4
m8cpjm0aw878
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-99.1
s1zkp592w4 bm
8 Nov 22
Adaptimmune Reports Third-Quarter Financial Results and Business Update
7:42am
8-K
EX-99.1
mmcasm 7jn5mz
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
8-K
69k6ohow zvp7b
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
424B5
1mp5c70
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-99.1
z3pj2yhg
14 Mar 22
Adaptimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
8:06am
8-K
EX-10.01
3q5nzb0zrb8m5
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
c1wtt9
12 Nov 21
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
6:30am